Update of carotid stent trials

Catheterization and Cardiovascular Interventions

Volumn 68, Issue 5, 2006, Pages 803-811

  Daniel, George K ^a,b  

^a John F Kennedy Medical Center   (United States)

^b Palm Beach Shoulder Service   (United States)

Author keywords

Carotid endartrectomy; Carotid stent; Stroke

Indexed keywords

NITINOL;

CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; EMBOLISM; HIGH RISK PATIENT; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; REVIEW; STENT; STROKE; TREATMENT OUTCOME;

BLOOD VESSEL PROSTHESIS IMPLANTATION; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CLINICAL TRIALS; DEVICE APPROVAL; ENDARTERECTOMY, CAROTID; HUMANS; INTRACRANIAL EMBOLISM; REGISTRIES; RISK FACTORS; STENTS; UNITED STATES;

EID: 33750940013     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.20888     Document Type: Review

References (26)

1. Chambers BR, Norris JW, Shurvell BL, Hachinski V. Prognosis of acute stroke. Neurology 1987;37:221-225.
2. Wolf PA, Kannel WB, McGee DL. Epidemiology of strokes in North America. In: Barnett HJM, Stein BM, Mohr JP, Yatsu FM, editors. Stroke: Pathophysiology, Diagnosis, and Management. New York: Churchill Livingstone; 1986. pp 19-29.
3. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade stenosis. N Engl J Med 1991;325:445-453.
4. European Carotid Surgery Trialists' Collaborative Group. MCR European Carotid Surgery Trial: Interim results for the symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet 1991;337:1235-1243.
5. Mayberg MR, Wilson SE, Yatsu F, VA Symptomatic Carotid Stenosis Group. Carotid endarterectomy and prevention of cerebral ischemia in symptomatic carotid stenosis. JAMA 1991;266:3289-3294.
6. Hobson RW, Weis DG, Fields WS, et al. Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. N Engl J Med 1993;328:221-227.
7. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid stenosis. JAMA 1995;273:1421-1428.
8. Wennberg DE, Lucas FL, Birkmeyer JD, et al. Variation in carotid endarterectomy mortality in the medicare population. JAMA 1998;279:1278-1281.
9. Joint Council of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter. Point of view: Statement regarding carotid angioplasty and stenting. J Vasc Surg 1996;24:900.
10. Gray W, ARCHeR Investigators. In: American College of Cardiology Annual Scientific Session, New Orleans, LA, 2004.
11. Guidant Endovascular Solutions, Inc. Clinical Update for Physicians, 2006. Guidant Endovascular Solutions, Inc., Santa Clara, CA 95054, USA.
12. Whilte CJ, Iyer SS, Hopkins N, Katzen BT, Russell ME. Carotid stenting with distal protection in high surgical risk patients: The BEACH Trial 30 day results. Catheter Cardiovasc Interv 2006;67:503-512.
13. Hopkins LN on behalf of theCABERNET Investigators.Caotid artery revascularization using the Boston Scientific EPI filter-Wire EX®/EZ™ and the EndoTex NexStent, Available at www.tctmd.com/csportal/appmanager/tctmd/ mam?_nfpb=true&_pageLabel=TCTMDContent&hdCon=1334907
14. Safian R, CREATE Investigators. Carotid revascularization with ev3 arterial technology evolution; (CREATE) Trial. Ev3, Inc., Plymouth, MN 55442-2111, USA. Available at: www.tctmd.com/csportal/appmanager/ tctmd/main?_nfpb=true&-pageLabel=TCTMD Content&hdCon= 1332283
15. Whitlow P, SECuRITY Investigatots. Registry study to evaluate the Neoroshield bare wire cerebral protection system and X-Act stent in patients at high risk for carotid endartrectomy (SECuRITY). Available at: www.tctmd.com/csportal/appmanager/tctmd/main?_nfpb=true&-pageLabel= TCTMDContent&hdCon=862458
16. Ramee SR, Higashida R, MAVErIC Investigators. Evaluation of the Medtronic self-expanding carotid stent system with distal protection in the treatment of carotid artery stenosis: The MAVErIC trial phase II 30-day update. Am J Cardiol 2004;94(Suppl. 6A):61E.
17. CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery transluminal Angioplasty Study (CAVATAS): A randomized trial. Lancet 2001;357:1729-1737.
18. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endartrectomy in high-risk patients. N Engl J Med 2004;351:1493-1501.
19. CaRESS Steering Committee. Carotid revascularization using endartrectomy or stenting systems (CaRESS) phase I clinical trial: 1 year results. J Vasc Surg 2005;42:213-219.
20. Hobson RW, Brott T, Ferguson R, Roubin G, et al. CREST: Carotid revascularization endartrectomy versus stent trial. Cardiovasc Surg 1997;5:457, 458.
21. Hobson RW, Ferguson R. Status report on the carotid revascularization endartrectomy versus stent trial. Tec Vasc Interv Radiol 2000;3:1-4.
22. EVA-3S Investigators. Endartrectomy vs. angioplasty in patients with symptomatic, severe carotid stenosis (EVA-3S) trial. Cerebrovasc Dis 2004;18:62-65.
23. EVA-3S Investigators. Carotid angioplasty and stenting with and without cerebral protection. Clinical alert from endartrectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial. Stroke 2004;35:e18-e20.
24. Ringleb PA, Kunze A, Allenberg, et al. The stem-supported percutaneous angioplasty of the Carotid Artery vs. Endartrectomy Trial. Cerebrovasc Dis 2004;18:66-68.
25. Featherstone RL, Brown MM, Coward LJ, et al. International carotid stenting study: Protocol for a randomized clinical trial comparing carotid stenting with endartrectomy in symptomatic carotid artery stenosis. Cerebrovasc Dis 2004;18:69-74.
26. Gray W, Yadav JS, Wholey M, Hopkins LN for theCAPTURE Investigators. In: American College of Cardiology Annual Scientific Session, Atlanta, GA, 2006.